期刊文献+

脐血干细胞移植治疗肝硬化失代偿后T淋巴细胞亚群的观察 被引量:5

Alteration of T-lymphocyte subsets after treated by cord blood-derived stem cells in patients with decompensated cirrhosis
下载PDF
导出
摘要 目的观察脐血干细胞移植对肝硬化失代偿患者免疫功能的影响。方法采用流式细胞术测定脐血干细胞治疗肝硬化失代偿前后患者总T细胞(CD3+)、T4细胞(CD3+CD4+)、T8细胞(CD3+CD8+)含量的变化。结果 51例肝硬化失代偿患者治疗前总T细胞、T4细胞、T8细胞含量及T4/T8比值分别为60.6±22.5、45.2±13.6、26.2±7.6和1.21±0.35,均明显低于健康对照组(P<0.05);脐血干细胞移植治疗1周后外周血总T细胞和T4细胞含量及T4/T8比值分别为68.5±17.6、51.2±14.6和1.71±0.65,均明显高于治疗前组(P<0.05);T8细胞含量21.3±8.5,明显低于治疗前组(P<0.05)。结论脐血干细胞治疗能有效改善肝硬化失代偿患者的免疫功能。 Objective To investigate the effect of cord blood-derived stem cells transplantation on immunologic function in patients with decompensated cirrhosis.Methods The content of T cell subsets of the patients with decompensated cirrhosis(DEC) who before and after treated with cord blood-derived stem cells transplantation was detected by flow cytometry.Results The study results shows that the concent of total T cells、T4 cells and T8 cells,the ratio of T4/T8 in decompensated cirrhosis was respectively 60.6±22.5,45.2±13.6,26.2±7.6,1.21±0.35,obviously higher than in control;After treated with cord blood-derived stem cells transplantation in DEC patients,the concent of total T ells、T4 cells and the ratio of T4/T8 were separately 68.5±17.6,51.2±14.6,1.71±0.65 and significantly higher than before treatment(P0.05);the content of T8 cells was 21.3±8.5 and definitely lower than before treatment(P0.05).Conclusion The transplantation of cord blood-derived stem cells on DEC patients can improve their function immunologic function significantly.
出处 《国际检验医学杂志》 CAS 2011年第20期2319-2320,共2页 International Journal of Laboratory Medicine
关键词 T淋巴细胞亚群 流式细胞术 脐血干细胞 失代偿肝硬化 T-lymphocyte subsets flow cytometry cord blood-derived stem cells decompensate cirrhosis
  • 相关文献

参考文献5

二级参考文献11

共引文献44

同被引文献69

  • 1任红英,赵钦军,邢文,杨少光,卢士红,任倩,张磊,韩忠朝.脐带间充质干细胞体外分化为有功能的低免疫原性肝细胞样细胞[J].中国医学科学院学报,2010,32(2):190-194. 被引量:24
  • 2刘浏,贾柳萍,杨冬华.骨髓干细胞移植与肝硬化[J].中国肝脏病杂志(电子版),2010,2(3):56-59. 被引量:1
  • 3KAWABATA A, OHTA N, SELLER G, et al. Nal've rat umbilical cord matrix stem cells significantly attenuate mammary tumor growth through modulation of endogenous immune responses[J}. Cytotherapy, 2013, 15(5): 586-597.
  • 4AYUZAWA R, DOI C, RACHAKATLA RS, et al. Naive humanumbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo[J]. Cancer lett, 2009, 280(1): 31-37.
  • 5Salama H, Zekri AR, Medhat E, et al. Peripheral vein infusion of autologous mesenchymal stem cells in EgyptianHCV-positive patients with end stage liver disease[J]. Stem Cell Res Ther,2014,5(3) :70. DOI: 10. l186/scrt459.
  • 6Uccelli A, de Rosbo NK. The immunomodulatory function of mesenchymal stem cells: mode of action and pathways[J]. Ann N Y Aead Sei, 2015,1351:114-126. DOI 10. llll/nyas. 12815.
  • 7Volarevic V, Nurkovic J, Arsenijevic N, et al. Concise review: Therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis [J]. Stem Cells, 2014,32 ( 11 ) : 2818-2823. DOI : 10. 1002/stem. 1818.
  • 8Herencia C, Almad4n Y, Martinez-Moreno JM,et al. Human mesenchymal stromal cell lysates as a novel strategy to recover liver function[J]. Regen Med, 2015,10 (1) : 25-38. DOI: 10. 2217/rme. 14.59.
  • 9Park M, Kim YH, Woo SY, et al. Tonsil-derived mesenchymal stem cells ameliorate CC14-induced liver fibrosis in mice via autophagy activation [J]. Sci Rep, 2015,5 : 8616 (2015-02-27) [2016-03-19]. http: //www. nature, com/articles/srep08616. DOI: 10. 1038/srep08616.
  • 10Gronthos S, Zannettino AC. A method to isolate and purify human bone marrow stromal stem cells [J]. Methods Mol Biol, 2008,449:45-57. DOI:10. 1007/978-1-60327-169-13.

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部